Biomarkers and immune-modulating therapies for Type 2 diabetes
Trends in Immunology, 08/16/2012
Brooks–Worrell B et al. – Recent advances in understanding the etiology of obesity, metabolic syndrome, and type 2 diabetes (T2D) have established involvement of the immune system. These developments highlight the potential of immunomodulatory therapies for treatment of these conditions.